Editorial: Antifungal Pipeline: Build It Strong; Build It Better!
作者信息
Perfect John R, Krysan Damian J, Del Poeta Maurizio, Selmecki Anna M, Brown Jessica C S, Cowen Leah E
机构信息
Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, United States.
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC, United States.
出版信息
Front Cell Infect Microbiol. 2022 Mar 16;12:881272. doi: 10.3389/fcimb.2022.881272. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Antifungal Pipeline: Build It Strong; Build It Better!社论：抗真菌药物研发渠道：筑牢根基；精益求精！
Front Cell Infect Microbiol. 2022 Mar 16;12:881272. doi: 10.3389/fcimb.2022.881272. eCollection 2022.
2
Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients.心脏移植受者侵袭性真菌感染的流行病学、危险因素及抗真菌预防的相关性。
Transpl Infect Dis. 2021 Oct;23(5):e13714. doi: 10.1111/tid.13714. Epub 2021 Sep 9.
3
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study.肝移植术后靶向抗真菌预防患者发生突破性侵袭性真菌感染：一项前瞻性多中心研究。
Transpl Infect Dis. 2021 Aug;23(4):e13608. doi: 10.1111/tid.13608. Epub 2021 May 3.
4
Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation.肺移植后针对与普遍预防策略预防侵袭性真菌感染的评估。
Transpl Infect Dis. 2021 Feb;23(1):e13448. doi: 10.1111/tid.13448. Epub 2020 Sep 1.
5
Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.异基因造血干细胞移植患者侵袭性真菌感染的管理：都灵经验。
Front Cell Infect Microbiol. 2022 Jan 7;11:805514. doi: 10.3389/fcimb.2021.805514. eCollection 2021.
6
Future Fungal Fighters in Dermatology: Novel Antifungal Drug Pipeline.未来皮肤科的抗真菌战士：新型抗真菌药物研发管线。
J Drugs Dermatol. 2022 May 1;21(5):496-501. doi: 10.36849/JDD.6373.
7
Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.异基因造血干细胞移植受者侵袭性真菌感染的二级抗真菌预防
J Infect Dev Ctries. 2018 Sep 30;12(9):799-805. doi: 10.3855/jidc.9961.
8
Breakthrough Invasive Fungal Infections in Patients with Acute Myeloid Leukemia.急性髓系白血病患者突破性侵袭性真菌感染。
Mycopathologia. 2020 Apr;185(2):299-306. doi: 10.1007/s11046-019-00418-8. Epub 2020 Jan 14.
9
Posaconazole salvage treatment for invasive fungal infection.泊沙康唑挽救治疗侵袭性真菌感染。
Mycopathologia. 2014 Oct;178(3-4):259-65. doi: 10.1007/s11046-014-9792-y. Epub 2014 Aug 8.
10
Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.高危心脏移植受者目标性抗真菌预防对早期侵袭性真菌感染的影响。
Transplantation. 2014 Jun 15;97(11):1192-7. doi: 10.1097/01.tp.0000441088.01723.ee.
引用本文的文献
1
Developing the trehalose biosynthesis pathway as an antifungal drug target.将海藻糖生物合成途径开发为抗真菌药物靶点。
NPJ Antimicrob Resist. 2025 Apr 14;3(1):30. doi: 10.1038/s44259-025-00095-2.
2
Recent developments in research: diversity, drugs, and disease.研究的最新进展：多样性、药物与疾病。
Microbiol Mol Biol Rev. 2025 Mar 27;89(1):e0001123. doi: 10.1128/mmbr.00011-23. Epub 2025 Feb 10.
3
Vitamin B5 metabolism is essential for vacuolar and mitochondrial functions and drug detoxification in fungi.维生素 B5 代谢对于真菌的液泡和线粒体功能以及药物解毒至关重要。
Commun Biol. 2024 Jul 23;7(1):894. doi: 10.1038/s42003-024-06595-7.
4
Candida albicans and Antifungal Peptides.白色念珠菌与抗真菌肽
Infect Dis Ther. 2023 Dec;12(12):2631-2648. doi: 10.1007/s40121-023-00889-9. Epub 2023 Nov 8.
5
Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of Candida albicans Vascular Catheter Infection and Candida auris Skin Colonization.新型酮基-烷基-吡啶鎓抗真菌分子在白色念珠菌血管导管感染和耳念珠菌皮肤定植模型中具有活性。
Antimicrob Agents Chemother. 2023 May 17;67(5):e0008123. doi: 10.1128/aac.00081-23. Epub 2023 Apr 25.
6
Strategies and opportunities for engineering antifungal peptides for therapeutic applications.用于治疗应用的工程抗真菌肽的策略和机会。
Curr Opin Biotechnol. 2023 Jun;81:102926. doi: 10.1016/j.copbio.2023.102926. Epub 2023 Apr 5.
7
Novel keto-alkyl-pyridinium antifungal molecules active in models of in vivo vascular catheter infection and ex vivo skin colonization.新型酮基烷基吡啶鎓抗真菌分子在体内血管导管感染模型和体外皮肤定植模型中具有活性。
bioRxiv. 2023 Jan 20:2023.01.19.524835. doi: 10.1101/2023.01.19.524835.
8
Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans.抗真菌药物浓度会影响白念珠菌适应性突变的谱。
Mol Biol Evol. 2023 Jan 4;40(1). doi: 10.1093/molbev/msad009.
本文引用的文献
1
Estimation of Direct Healthcare Costs of Fungal Diseases in the United States.美国真菌病直接医疗成本估算。
Clin Infect Dis. 2019 May 17;68(11):1791-1797. doi: 10.1093/cid/ciy776.
2
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision.全球及多国真菌病患病率——估计精度
J Fungi (Basel). 2017 Oct 18;3(4):57. doi: 10.3390/jof3040057.
3
The antifungal pipeline: a reality check.抗真菌药物研发进展：现实审视。
Nat Rev Drug Discov. 2017 Sep;16(9):603-616. doi: 10.1038/nrd.2017.46. Epub 2017 May 12.
4
Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research.抗真菌研究中的泛分析干扰化合物（PAINS）及其他混杂化合物
J Med Chem. 2016 Jan 28;59(2):497-503. doi: 10.1021/acs.jmedchem.5b00361. Epub 2015 Sep 8.
Zotero 插件